5-aminolevulinic acid-induced fluorescence cystoscopy for photodynamic diagnosis of bladder tumors: Oral versus intravesical administration.

Objective: This retrospective study aimed at comparing orally administered 5-aminolevulinic acid (5-ALA) to the intravesical (IV) route for the Materials and Methods: A comparative retrospective review was conducted on adult patients who underwent 5-ALA-assisted cystoscopy for bladder tumor detection. Participants were divided into Group A, who received oral (ALA onco) powder, while Group B received 5-ALA intravesically. A comprehensive assessment, including patient history, physical examination, cytological urine analysis, ultrasound, and computed tomography scans, was performed. The sensitivity and specificity of white light cystoscopy were compared to PDD cystoscopy using both 5-ALA administration routes. Furthermore, the diagnostic accuracy of the oral versus the intarvesical route was directly compared. The associated toxicities were also identified. Patients were further categorized based on the morphological presence of muscle invasion. A further subgroup statistical analysis for the nonmuscle invasive category was carried out. Chi-square test was used to calculate ( Results: A total of 88 participants were included. Group A comprised 10 patients (8 males, aged 40-70 years), while Group B included 78 patients (58 males, aged 29-75 years). Oral 5-ALA demonstrated a sensitivity of 96%, compared to 60% for white light with a statistically significant difference ( Conclusion: PDD using oral 5-ALA demonstrated superior diagnostic accuracy compared to IV administration and white light cystoscopy along with lower recurrence rate, making it the preferable option while larger scale and more powered studies are awaited.